Patent ID: 8354240
Filing Date: 2013-01-15
Classification: A61K,C07B,C07K,G01N,G11B,Y02A

Abstract:
1. A method of assaying for Borrelia infection comprising: (a) contacting a sample obtained from a subject with an isolated polypeptide consisting of an epitope of SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, or SEQ ID NO:30; and (b) determining whether immunologic binding occurs between the isolated polypeptide and an antibody in the sample, wherein immunologic binding is indicative of